Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of the American Society for Mass Spectrometry|March 21, 2020
High Mass Analysis with a Fourier Transform Ion Cyclotron Resonance Mass Spectrometer: From Inorganic Salt Clusters to Antibody Conjugates and BeyondIain D G Campuzano, Michael Nshanian, Christopher Spahr, et al.
Analytical Chemistry|December 2, 2017
Native-MS Analysis of Monoclonal Antibody Conjugates by Fourier Transform Ion Cyclotron Resonance Mass SpectrometryIain D G Campuzano, Chawita Netirojjanakul, Michael Nshanian, et al.
Bioconjugate Chemistry|June 16, 2015
Synthetically Modified Viral Capsids as Versatile Carriers for Use in Antibody-Based Cell TargetingAdel M ElSohly, Chawita Netirojjanakul, Ioana L Aanei, et al.
Molecular Pharmaceutics|September 10, 2016
Biodistribution of Antibody-MS2 Viral Capsid Conjugates in Breast Cancer ModelsIoana L Aanei, Adel M ElSohly, Michelle E Farkas, et al.
Journal of the American Society for Mass Spectrometry|October 7, 2022
High-Throughput Mass Spectrometry for Biopharma: A Universal Modality and Target Independent Analytical Method for Accurate Biomolecule CharacterizationIain D G Campuzano, Emma M Pelegri-O'Day, Nithya Srinivasan, et al.
Analytical Chemistry|June 14, 2019
Native and Denaturing MS Protein Deconvolution for Biopharma: Monoclonal Antibodies and Antibody-Drug Conjugates to Polydisperse Membrane Proteins and BeyondIain D G Campuzano, John H Robinson, John O Hui, et al.
Cell Reports. Medicine|June 7, 2021
GIPR antagonist antibodies conjugated to GLP-1 peptide are bispecific molecules that decrease weight in obese mice and monkeysShu-Chen Lu, Michelle Chen, Larissa Atangan, et al.
Frontiers in Immunology|April 7, 2025
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapyBreanna DiAndreth, Pavlo A Nesterenko, Aaron G Winters, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of ObesityBin Wu, James R Falsey, Chawita Netirojjanakul, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 8, 2019
Use of Cryopreserved Hepatocytes as Part of an Integrated Strategy to Characterize In Vivo Clearance for Peptide-Antibody Conjugate Inhibitors of Nav1.7 in Preclinical SpeciesRobert S Foti, Kaustav Biswas, Jennifer Aral, et al.
Pageof 3